127 related articles for article (PubMed ID: 7863231)
21. Reversal of acute coagulopathy during hypotensive resuscitation using small-volume 7.5% NaCl adenocaine and Mg2+ in the rat model of severe hemorrhagic shock.
Letson HL; Pecheniuk NM; Mhango LP; Dobson GP
Crit Care Med; 2012 Aug; 40(8):2417-22. PubMed ID: 22809911
[TBL] [Abstract][Full Text] [Related]
22. Standardization of coagulation tests.
Opartkiattikul N
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
[TBL] [Abstract][Full Text] [Related]
23. A novel congenital haemostatic defect: combined factor VII and factor XI deficiency.
Bérubé C; Ofosu FA; Kelton JG; Blajchman MA
Blood Coagul Fibrinolysis; 1992 Aug; 3(4):357-60. PubMed ID: 1420812
[TBL] [Abstract][Full Text] [Related]
24. [Activity of coagulation factors in liver coma caused by viral hepatitis].
Esposito R; Almaviva M; Rinaldi E; De Lalla F
Boll Ist Sieroter Milan; 1979 Mar; 58(1):41-7. PubMed ID: 552833
[TBL] [Abstract][Full Text] [Related]
25. Comparison of functional aspects of the coagulation cascade in human and sea turtle plasmas.
Soslau G; Wallace B; Vicente C; Goldenberg SJ; Tupis T; Spotila J; George R; Paladino F; Whitaker B; Violetta G; Piedra R
Comp Biochem Physiol B Biochem Mol Biol; 2004 Aug; 138(4):399-406. PubMed ID: 15325341
[TBL] [Abstract][Full Text] [Related]
26. The inhibitor of prothrombin conversion in plasma of patients on oral anticoagulant treatment.
Bertina RM; Westhoek-Kuipers ME; Alderkamp GH
Thromb Haemost; 1981 Jun; 45(3):237-41. PubMed ID: 7281102
[TBL] [Abstract][Full Text] [Related]
27. Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects.
Eerenberg ES; Kamphuisen PW; Sijpkens MK; Meijers JC; Buller HR; Levi M
Circulation; 2011 Oct; 124(14):1573-9. PubMed ID: 21900088
[TBL] [Abstract][Full Text] [Related]
28. Hypercoagulability in patients with chronic noncirrhotic portal vein thrombosis.
Raffa S; Reverter JC; Seijo S; Tassies D; Abraldes JG; Bosch J; García-Pagán JC
Clin Gastroenterol Hepatol; 2012 Jan; 10(1):72-8. PubMed ID: 21946303
[TBL] [Abstract][Full Text] [Related]
29. [A study of intrapartum and postpartum bleeding based on changes in blood coagulation and fibrinolysis during pregnancy].
Fuse Y
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Mar; 39(3):405-10. PubMed ID: 3494090
[TBL] [Abstract][Full Text] [Related]
30. Parecoxib sodium, an injectable COX-2-specific inhibitor, does not affect unfractionated heparin-regulated blood coagulation parameters.
Noveck RJ; Hubbard RC
J Clin Pharmacol; 2004 May; 44(5):474-80. PubMed ID: 15102867
[TBL] [Abstract][Full Text] [Related]
31. Prolongation of the prothrombin time and activated partial thromboplastin time in children with sickle cell disease.
Raffini LJ; Niebanck AE; Hrusovsky J; Stevens A; Blackwood-Chirchir A; Ohene-Frempong K; Kwiatkowski JL
Pediatr Blood Cancer; 2006 Oct; 47(5):589-93. PubMed ID: 16123995
[TBL] [Abstract][Full Text] [Related]
32. Activated partial thromboplastin time correlates with methoxyhydroxyphenylglycol in acute myocardial infarction patients: therapeutic implications for patients at cardiovascular risk.
Pinelli A; Trivulzio S; Rossoni G
In Vivo; 2014; 28(1):99-104. PubMed ID: 24425842
[TBL] [Abstract][Full Text] [Related]
33. Oral anticoagulant therapy and international normalized ratios in swine.
McGlasson DL; Brickey DA; Doe RH
Lab Anim Sci; 1998 Aug; 48(4):371-3. PubMed ID: 10090045
[TBL] [Abstract][Full Text] [Related]
34. Hypoperfusion in severely injured trauma patients is associated with reduced coagulation factor activity.
Jansen JO; Scarpelini S; Pinto R; Tien HC; Callum J; Rizoli SB
J Trauma; 2011 Nov; 71(5 Suppl 1):S435-40. PubMed ID: 22072000
[TBL] [Abstract][Full Text] [Related]
35. Prothrombin time and partial thromboplastin time assay considerations.
Ng VL
Clin Lab Med; 2009 Jun; 29(2):253-63. PubMed ID: 19665677
[TBL] [Abstract][Full Text] [Related]
36. Kinetic aspects of the interaction of blood-clotting enzymes. II. The relation between clotting time and plasma concentration in prothrombin-time estimations.
Hemker HC; Siepel T; Altman R; Loeliger EA
Thromb Diath Haemorrh; 1967 May; 17(3-4):349-57. PubMed ID: 5589294
[No Abstract] [Full Text] [Related]
37. Hypothermia and blood coagulation: dissociation between enzyme activity and clotting factor levels.
Reed RL; Bracey AW; Hudson JD; Miller TA; Fischer RP
Circ Shock; 1990 Oct; 32(2):141-52. PubMed ID: 2253317
[TBL] [Abstract][Full Text] [Related]
38. Thrombin generation in normal plasma enriched with purified coagulation factors.
Triantaphyllopoulos DC; Leech SC
Thromb Res; 1983 Feb; 29(3):355-69. PubMed ID: 6845284
[TBL] [Abstract][Full Text] [Related]
39. In vitro study of N-acetylcysteine on coagulation factors in plasma samples from healthy subjects.
Jang DH; Weaver MD; Pizon AF
J Med Toxicol; 2013 Mar; 9(1):49-53. PubMed ID: 22733602
[TBL] [Abstract][Full Text] [Related]
40. Assessment of factors II, VII, IX, X, and protein C in hepatosplenic schistosomiasis.
Amin HM; Omran SA; el-Bassuoni NE; el-Kaliouby AH; el-Ashmawy SA
Haemostasis; 1994; 24(1):22-6. PubMed ID: 7959352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
